Design Therapeutics competitorsClear all

Design Therapeutics's top competitors include Kamada Pharmaceuticals, Immunicum and Escient Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Design Therapeutics
Design Therapeutics
Design Therapeutics is a biotechnology company that develops therapies for serious degenerative disorders caused by nucleotide repeat expansions.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Immunicum
Immunicum
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
Escient Pharmaceuticals
Escient Pharmaceuticals
Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.
Founding Date
Founding Date
2017
Founding Date
1990
Founding Date
2002
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Carlsbad, US HQ
New York, US
San Diego, US
San Diego, US
Locations
Rehovot, IL HQ
Beit Kama, IL
Locations
Stockholm, SE HQ
Leiden, NL
Locations
San Diego, US HQ
Employees
Employees
22
Employees
408
Employees
29
Employees
39
Valuation ($)
Valuation ($)
634.6 m
Valuation ($)
209.5 m
Valuation ($)
47.1 m
Valuation ($)
N/A
Alexa Website Rank
Alexa Website Rank
358868
Alexa Website Rank
859663
Alexa Website Rank
546679
Alexa Website Rank
136663
Employee Rating
Employee Rating
N/A
Employee Rating
3.7
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$103.6m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
($52.8m) (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$50.9m (FY, 2021)
Gross profit
kr31k (FY, 2021)
Gross profit
N/A
Net income
Net income
N/A
Net income
($2.2m) (FY, 2021)
Net income
(kr133.4m) (FY, 2021)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 45m
Total funding raised
$ 90m
Total funding raised
N/A
Total funding raised
$ 117.5m
For sources of this data, please see the company profile

View company profiles

Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
408

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company
Immunicum
HQ
Stockholm, SE
Employees
29

Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.

View company
Escient Pharmaceuticals
HQ
San Diego, US
Employees
39

Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.

View company